SEPTInvestingStart Free

BFRI SCHEDULE 13G/A: SEC filing

Rosalind Advisors, Inc. and related reporting persons

Filed with the SEC on · accession 0001622627-26-000031

BFRI filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 13, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -24.4% by the first close after the filing.

Summary of the filing

Rosalind Advisors, Inc. and related reporting persons filed an amended Schedule 13G disclosing beneficial ownership of approximately 9.9% of Biofrontera Inc.'s common stock, consisting of 1,789,288 shares held directly plus preferred shares and convertible debt subject to 9.99% blocker provisions.

For details, click here →

Key details

Shares of Common Stock beneficially owned$1.8M
Shares issuable upon exercise of preferred shares$11.1M
Shares issuable upon exercise of convertible debt$3.0M
Total shares reported on cover page (subject to blockers)$15.9M
Issuer's outstanding common stock as of October 4, 2026$17.9M
Issuer of the securitiesBiofrontera Inc.
Reporting person / investment advisorRosalind Advisors, Inc.
Reporting person / beneficial ownerRosalind Master Fund L.P.
General partner to rosalind master fund l.p.Rosalind (Cayman) Ltd.
President of rosalind advisors, inc. and portfolio managerSteven Salamon
Portfolio manager and member of rosalind advisors, inc.Gilad Aharon
Director of rosalind (cayman) ltd., general partner to rosalind master fund l.p.Mike McDonald

How BFRI stock reacted

Close before

$0.93

Nov 12, 2026

First close after

-24.39%

$0.70

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for BFRI, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for BFRI?

Click here

Frequently asked questions

What did BFRI file with the SEC on Nov 13, 2026?

BFRI filed a SCHEDULE 13G/A (SEC filing). Rosalind Advisors, Inc. and related reporting persons filed an amended Schedule 13G disclosing beneficial ownership of approximately 9.9% of Biofrontera Inc.'s common stock, consisting of 1,789,288 shares held directly plus preferred shares and convertible debt subject to 9.99% blocker provisions.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did BFRI stock react to this filing?

BFRI closed at $0.93 before the filing and $0.70 on Nov 13, 2026 (-24.39%).

Other BFRI SEC filings

Get alerts when BFRI files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
BFRI overviewBFRI analysisBFRI newsLatest SEC filings